Deutsche, Goldman Arrange Facility to Support Mylan $7.2B Deal
Drug maker Mylan will buy Swedish drug maker Meda in a $7.2 billion deal. Mylan will finance the cash portion of the offer with a new bridge credit facility arranged by Deutsche Bank Securities and Goldman Sachs.
February 11, 2016
Deutsche Bank Securities | Goldman Sachs Bank USA | Meda | Mylan
ABF Journal